EMCURE

Emcure Pharmaceuticals LimitedNSELive
₹1,913.3+52.10 (+2.80%)

Market Open · NSE · INR

Open

₹1,879

High

₹1,920

Low

₹1,874

Prev Close

₹1,861.2

52-Week Range100% from low
₹1,271.8
₹1,913.3

Market Cap

₹35.30 K Cr

Large Cap

P/E (TTM)

38.16

EPS

₹48.77

Div Yield

0.16%

P/B Ratio

-

ROE

18.9%

Key Metrics

Forward P/E24.63
Book Value-
Debt/Equity0.24×
Revenue Growth16.7%
Profit Margin9.87%
Operating Margin-
Volume1.95 L
Avg Volume (20d)2.11 L
Delivery %53.71%
Trades15,443

Analyst Ratings(7 analysts)

Strong Buy

Target Price

₹1,963

+2.6% upside

Strong Buy1
Buy5
Hold1
Low: ₹1,640Median: ₹1,965High: ₹2,260

Current price: ₹1,913

Upcoming Events

Earnings Date
06 Aug 2026

What If I Had Invested?

Chart data not available for this range

AI Analysis

Get AI-powered sentiment analysis, strengths, risks, and outlook for this stock.

AI Technical Analysis

Buy/sell zones with live web research

Get AI-generated buy zones, sell targets, stop-loss levels and a technical narrative — powered by AI with live web search for the latest news and analyst moves.

Patterns are measured on real price data, then AI-validated. Pattern detection is free when nothing clean is found.

About

HealthcareDrug Manufacturers - Specialty & Generic

Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide. It offers products in various therapeutic areas, such gynecology, anti-infectives, pain/analgesics, Vitamins, Minerals & Nutrients, blood-related, oncology, respiratory, HIV antivirals, gastro, anti-diabeti...

emcure.com6,731 employees

Technical Indicators

Loading sector benchmark…

Quality scores

Valuation bands

Intrinsic value calculators

Peer Comparison

Dividend History

Recent: 3.00/share
14 Aug 20253.00
Loading events…

Recent Filings (NSE)

Raw NSE filings — full text + attachments. Tap any row for an AI summary that explains what it means for the stock.

Institutional Deals(NSE)

Source: NSE India. Block deals ≥5L shares or ≥₹10Cr. Bulk deals ≥0.5% of shares.

Governance Scorecard

AlphaView composite

Fund Actions

Loading fund activity…

News

News sourced from RSS feeds. Headlines link to original articles.

Disclaimer: This is AI-generated educational information, not investment advice. Stock data is delayed by up to 15 minutes. Past performance does not guarantee future results. Please consult a SEBI-registered investment advisor before making investment decisions.